Termination in Connection With Additional Studies Sample Clauses

Termination in Connection With Additional Studies. If, pursuant to Section 4.8, the PDC does not receive the approval of the JEC to undertake the additional clinical studies required by the FDA within 90 days of making its formal recommendation of its conclusions to the JEC, then any Party may terminate this Agreement effective immediately upon giving the other Parties notice of such termination.
Sample 1Sample 2Sample 3See All (4)
AutoNDA by SimpleDocs
Termination in Connection With Additional Studies. If, pursuant to Section 4.7, the PDC does not receive the approval of the JEC to undertake the additional clinical studies required by the FDA within *** days of making its formal recommendation of its conclusions to the JEC, then Endo may terminate this Agreement effective immediately upon giving DURECT notice of such termination. In the event of such a termination by Endo, DURECT shall pay to Endo *** of all proceeds and other consideration received by DURECT and its Affiliates in the subsequent *** years in connection with sales of (or permitting Third Parties to sell) Product or Finished Product in the Territory, pursuant to the payments and reports procedures set forth in Section 7 (substituting DURECT for Endo and Endo for DURECT, and the proceeds under this Section 13.4 for Distribution Fees, therein). In the event that Endo does not elect to terminate this Agreement under this Section 13.4, then (i) Endo may elect to pay for such additional clinical studies required by the FDA, and shall be entitled to reduce (A) by ***% any payments otherwise due and owing to DURECT hereunder until Endo has recovered through such reductions an amount equal to *** % of all costs incurred by Endo in connection with such additional clinical studies and (B) the Distribution Fee by *** for a period of *** years from such election, or (ii) if Endo does not so elect to pay for such additional clinical studies required by the FDA, then DURECT may elect to pay for such additional clinical studies and shall be entitled to receive from Endo an increase of (A) ***% of any payments otherwise due and owing to DURECT hereunder until DURECT has recovered through such increases an amount equal to ***% of all costs incurred by DURECT in connection with such additional clinical studies and (B) *** of the Distribution Fee for a period of *** years from such election. The other Party shall fully cooperate with the Party paying for such additional clinical studies under this Section 13.4. If neither Party elects to pay for any such additional clinical studies, then this Agreement shall terminate.
Sample 1
Termination in Connection With Additional Studies. 13.5 Termination in Connection with Bankruptcy........................................................ 13.6
Sample 1

Related to Termination in Connection With Additional Studies

  • Termination in Connection with Change of Control If Executive’s employment is terminated by the Company without Cause or by Executive for Good Reason within sixty (60) days prior to or twelve (12) months following a Change of Control, Executive shall be entitled to receive, in lieu of any severance benefits to which Executive may otherwise be entitled under any severance plan or program of the Company, the benefits provided below:

  • Termination in Connection with a Change of Control If the Executive’s employment is terminated by the Company other than for Cause or by the Executive for Good Reason during the Effective Period, then the Executive shall be entitled to receive the following from the Company:

  • Termination in Connection with Change in Control a. This Agreement terminates if it is not assumed by the successor corporation (or affiliate thereto) upon a Change in Control (as defined below).

  • Termination in Connection with a Change in Control a. For purposes of this Agreement, a “

  • Termination with Notice Either the Director or the Company may terminate this Agreement by providing at least thirty (30) days prior written notice to the other party.

  • In Connection With a Change in Control If the Company (or its successor) terminates the Executive’s employment without Cause or the Executive terminates his employment for Good Reason within the period commencing three (3) months immediately prior to a Change in Control of the Company and ending eighteen (18) months immediately following a Change in Control of the Company (as defined in Section 4.5.4 of this Agreement), the Executive shall receive the Accrued Amounts subject to standard deductions and withholdings, to be paid as a lump sum no later than thirty (30) days after the date of termination. In addition, subject to the limitations stated in this Agreement and upon the Executive’s furnishing to the Company (or its successor) an executed Release within the applicable time period set forth therein, but in no event later than forty-five days following termination of employment and permitting such Release to become effective in accordance with its terms, and subject to Executive entering into no later than the Release Effective Date a non-competition agreement to be effective during the Severance Period, substantially similar to Section 2.3, and continuing to abide by its terms during the Severance Period, then in lieu of (and not additional to) the benefits provided pursuant to Section 4.4.3(i) above, the Executive shall be entitled to:

  • CONTRIBUTION IN THE EVENT OF JOINT LIABILITY (a) To the fullest extent permissible under applicable law, if the indemnification, hold harmless and/or exoneration rights provided for in this Agreement are unavailable to Indemnitee in whole or in part for any reason whatsoever, the Company, in lieu of indemnifying, holding harmless or exonerating Indemnitee, shall pay, in the first instance, the entire amount incurred by Indemnitee, whether for judgments, liabilities, fines, penalties, amounts paid or to be paid in settlement and/or for Expenses, in connection with any Proceeding without requiring Indemnitee to contribute to such payment, and the Company hereby waives and relinquishes any right of contribution it may have at any time against Indemnitee.

  • Termination of Related Party Agreements Except as set forth on Schedule 9.7, all existing agreements between the Company and the Stockholders (and between the Company and entities controlled by the Stockholders) shall have been canceled effective prior to or as of the Consummation Date.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!